相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biomarkers for diabetes prediction, pathogenesis or pharmacotherapy guidance? Past, present and future possibilities
N. Sattar
DIABETIC MEDICINE (2012)
The Journey to Regulation of Protein-Based Multiplex Quantitative Assays
Emily S. Boja et al.
CLINICAL CHEMISTRY (2011)
Ethical aspects of human biobanks: a systematic review
Danijela Budimir et al.
CROATIAN MEDICAL JOURNAL (2011)
Realizing the promise of population biobanks: a new model for translation
Madeleine J. Murtagh et al.
HUMAN GENETICS (2011)
From single biobanks to international networks: developing e-governance
Jane Kaye
HUMAN GENETICS (2011)
Comparison of Effect Sizes Associated With Biomarkers Reported in Highly Cited Individual Articles and in Subsequent Meta-analyses
John P. A. Ioannidis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
European Biobanks Forge Cross-Border Ties
Bryan Keogh
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Comprehensive catalog of European biobanks
H-Erich Wichmann et al.
NATURE BIOTECHNOLOGY (2011)
Olmesartan for the Delay or Prevention of Microalbuminuria in Type 2 Diabetes
Hermann Haller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
New pathway for qualification of novel methodologies in the European medicines agency
Efthymios Manolis et al.
PROTEOMICS CLINICAL APPLICATIONS (2011)
A roadmap for successful applications of clinical proteomics
John P. A. Ioannidis
PROTEOMICS CLINICAL APPLICATIONS (2011)
Proteomics in chronic kidney disease: The issues clinical nephrologists need an answer for
Goce Spasovski et al.
PROTEOMICS CLINICAL APPLICATIONS (2011)
A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer
Elizabeth R. Remily-Wood et al.
PROTEOMICS CLINICAL APPLICATIONS (2011)
Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications
Petra Zuerbig et al.
PROTEOMICS CLINICAL APPLICATIONS (2011)
Genomics, Biobanks, and the Trade-Secret Model
Robert Mitchell et al.
SCIENCE (2011)
Improving Validation Practices in Omics Research
John P. A. Ioannidis et al.
SCIENCE (2011)
AACR-FDA-NCI Cancer Biomarkers Collaborative Consensus Report: Advancing the Use of Biomarkers in Cancer Drug Development
Samir N. Khleif et al.
CLINICAL CANCER RESEARCH (2010)
The Clinical Plasma Proteome: A Survey of Clinical Assays for Proteins in Plasma and Serum
N. Leigh Anderson
CLINICAL CHEMISTRY (2010)
Mass Spectrometry-Based Proteomic Diagnosis of Renal Immunoglobulin Heavy Chain Amyloidosis
Sanjeev Sethi et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Personal genomics: information can be harmful
D. F. Ransohoff et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
What Makes a Good Predictor? The Evidence Applied to Coronary Artery Calcium Score
John P. A. Ioannidis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Cancer Biomarkers: Can We Turn Recent Failures into Success?
Eleftherios P. Diamandis
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
David M. Good et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Proteomic biomarkers in diabetic nephropathy-reality or future promise?
Harald Mischak et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Basic and clinical proteomics from the EU Health Research perspective
Tomasz Dylag et al.
PROTEOMICS CLINICAL APPLICATIONS (2010)
Recommendations for Biomarker Identification and Qualification in Clinical Proteomics
Harald Mischak et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes Three Randomized Trials
Rudy Bilous et al.
ANNALS OF INTERNAL MEDICINE (2009)
Development of High-Throughput Mass Spectrometry-Based Approaches for Cancer Biomarker Discovery and Implementation
Brian L. Hood et al.
CLINICS IN LABORATORY MEDICINE (2009)
Method validation of protein biomarkers in support of drug development or clinical diagnosis/prognosis
Jean W. Lee et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2009)
Common Sense Approaches to Urinary Biomarker Study Design
Mark A. Knepper
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Urinary Peptidome May Predict Renal Function Decline in Type 1 Diabetes and Microalbuminuria
Michael L. Merchant et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Identification and Validation of Urinary Biomarkers for Differential Diagnosis and Evaluation of Therapeutic Intervention in Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
Marion Haubitz et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Validation of Analytic Methods for Biomarkers Used in Drug Development
Cindy H. Chau et al.
CLINICAL CANCER RESEARCH (2008)
Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
Nish Chaturvedi et al.
LANCET (2008)
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial
Anne Katrin Sjolie et al.
LANCET (2008)
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
A. Patel et al.
LANCET (2007)
Clinical proteomics: A need to define the field and to begin to set adequate standards
Harald Mischak et al.
PROTEOMICS CLINICAL APPLICATIONS (2007)
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Nader Rifai et al.
NATURE BIOTECHNOLOGY (2006)
Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility
OJ Semmes et al.
CLINICAL CHEMISTRY (2005)
Preventing microalbuminuria in type 2 diabetes
P Ruggenenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
